CalciMedica, Inc. (CALC) vs Liminatus Pharma, Inc. Class A Common Stock (LIMN)
A side-by-side comparison of CalciMedica, Inc. and Liminatus Pharma, Inc. Class A Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CALC
CalciMedica, Inc.
$1.48HealthcareDelayed quote: Oct 6, 2026, 12:08 PM EDT
LIMN
Liminatus Pharma, Inc. Class A Common Stock
$3.85HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — CALC vs LIMN
growth of $100 · dividends reinvested · last 1yCALC -79.6% (-79.6%/yr)LIMN -98.4% (-98.4%/yr)CALC compounded faster over this window
Log scale — wide-divergence pair
CALC LIMN
CALC vs LIMN: by the numbers
- •LIMN is the larger company ($5M vs $5M market cap).
Metrics side by side
Valuation
| Metric | CALC | LIMN |
|---|---|---|
| P/B ratio | 0.85 | 17.20 |
Profitability
| Metric | CALC | LIMN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -385.27% | -4165.92% |
| ROIC | -122.56% | -225.12% |
Go deeper
Dig into the metrics
CalciMedica ROELiminatus Pharma, Inc. Class A Common Stock ROECalciMedica operating marginLiminatus Pharma, Inc. Class A Common Stock operating marginCalciMedica revenue growthLiminatus Pharma, Inc. Class A Common Stock revenue growthCalciMedica free cash flowLiminatus Pharma, Inc. Class A Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.